Medios AG (VIE:ILM1)

Market Cap	400.95M +30.5%
Revenue (ttm)	2.01B +9.3%
Net Income	22.03M +71.1%
EPS	0.87 +65.0%
Shares Out	n/a
PE Ratio	18.20
Forward PE	13.01
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	67
Open	15.56
Previous Close	15.82
Day's Range	15.56 - 15.74
52-Week Range	10.36 - 16.64
Beta	n/a
RSI	57.64
Earnings Date	Mar 26, 2026

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• CEO: Matthias Gaertner
• Employees: 999
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: ILM1

Financial Performance

In 2024, Medios AG's revenue was 1.88 billion, an increase of 5.51% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.